Thyroid cancer surgery guidelines in an era of de-escalation

KJ Kovatch, CW Hoban, AG Shuman - European Journal of Surgical …, 2018 - Elsevier
… questioning whether all cases of thyroid cancer merit a treatment approach focused on …
-based treatment de-escalation paradigms reflect better risk stratification of thyroid cancers, and …

[HTML][HTML] Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation

ET Pavlidis, TE Pavlidis - World Journal of Clinical Oncology, 2023 - ncbi.nlm.nih.gov
… Core Tip: Nodal status in papillary thyroid cancer patients plays an … in patients with
papillary thyroid carcinoma with negative … and in an ongoing controversy in the era of de-escalation. …

Low-risk papillary thyroid cancer: Treatment de-escalation and cost implications

CM Paluskievicz, DR Chang, KW Blackburn… - Journal of Surgical …, 2022 - Elsevier
… We hypothesized that there has been significant treatment de-escalation in the years
surrounding these guidelines and that the corresponding cost-per-patient for treatment of low-risk …

[HTML][HTML] The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment

G Grani, L Ciotti, V Del Gatto, T Montesano, M Biffoni… - Endocrine, 2022 - Springer
… Indeed, a de-escalation process of care and a risk-adapted approach to thyroid cancer
the diagnostic workup of thyroid nodules and for the treatment and follow-up of diagnosed …

Association between implementation of the 2009 American Thyroid Association guidelines and de-escalation of treatment for low-risk papillary thyroid carcinoma

S Lohia, LGT Morris, BR Roman - JAMA Otolaryngology–Head & …, 2020 - jamanetwork.com
De-escalation of therapy for papillary thyroid carcinoma (PTC) has been evolving in American
Thyroid … with ATA low-risk category cancers, ie, patients with PTC tumors of 4 cm or smaller…

Follow-up After Low-Risk Papillary Microcarcinoma: De-escalation Is Appropriate Except in Cases with Vascular Invasion

CW Rowe - Clinical Thyroidology, 2023 - liebertpub.com
thyroid cancers have a low risk of recurrence and a very low risk of disease-specific mortality.
This is particularly true for small, often coincidentally detected, papillary thyroid carcinomas

Insurance-based disparities in guideline-concordant thyroid cancer care in the era of de-escalation

SP Ginzberg, JMS Ballester, CJ Wirtalla… - Journal of Surgical …, 2023 - Elsevier
… In conclusion, this analysis of thyroid cancer care in the era of the 2015 ATA guidelines
demonstrates persistent disparities in presentation and treatment for patients with Medicaid …

Hemithyroidectomy for medullary thyroid carcinoma: possible de-escalation strategy based on preoperative calcitonin levels

H Coerts, D Aykan, L Lodewijk, WE Visser… - European Journal of …, 2024 - ejso.com
… Conclusions: This study indicates that in a clinical trial context, there is potential for surgical
de-escalation in patients with unilateral, sporadic cN0M0 medullary thyroid carcinoma with a …

Surgical De-Escalation in Medullary Thyroid Cancer: A Commentary

SP Ginzberg, LN Krumeich - The Oncologist, 2023 - academic.oup.com
… -escalate surgery for thyroid cancer. In well-differentiated thyroid cancer, data demonstrating
non-… An additional concern regarding de-escalation of surgery is its psychological impact on …

Current patterns of care in low‐risk thyroid cancer—A national cross‐sectional survey of Australian thyroid clinicians

W Widjaja, CW Rowe, C Oldmeadow… - Endocrinology …, 2023 - Wiley Online Library
… has been a move towards de-escalation of treatment for low-risk thyroid cancer. This study
aimed to evaluate preferences for uptake of de-escalation of initial management and follow-…